WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Sees Strong Trading Volume – Still a Buy?

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) saw an uptick in trading volume on Thursday . Approximately 256,992 shares changed hands during mid-day trading, an increase of 265% from the previous session’s volume of 70,444 shares.The stock last traded at $12.30 and had previously closed at $12.54.

Wall Street Analyst Weigh In

Separately, Zacks Research raised WuXi Biologics (Cayman) to a “hold” rating in a research note on Friday, August 28th. One research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock presently has a consensus rating of “Hold”.

WuXi Biologics (Cayman) Trading Up 0.9%

The firm has a fifty day moving average of $11.31 and a 200-day moving average of $9.58.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company provides integrated services to pharmaceutical and biotechnology customers across the development cycle, from early-stage discovery and preclinical research through clinical development, regulatory support and commercial manufacturing.

Its capabilities include the development and production of monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates and other biologic modalities.